Regulus Therapeutics Raises $20M
socalTECH
MARCH 4, 2009
The investment came from Alnylam Pharmaceuticals and Isis Pharmaceuticals, which created Regulus in a joint venture in September of 2007. According to Regulus, the new funding will provide it with cash to operate through 2011. Regulus also said that it now has over 900 patents focused on microRNA technology.
Let's personalize your content